| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |